D3 Bio

德昇济医药D3 Bio

D3 Bio

Biotech/Healthcare

Deshengi Pharmaceuticals was founded in 2020 and is committed to developing oncology and precision immunotherapy drugs guided by clinical value, with the goal of benefiting patients worldwide. The company’s co-founder, Dr.

Latest round: Series B (2025)

Source: ChinaBulls — chinabulls.com

Last updated 2025-12-01